To assess the safety of 3 serial vaccinations with allogeneic DCs: autologous tumor-derived cells subjected to electrofusion in patients with AJCC stage IV RCC
To determine if 3 serial vaccinations of allogeneic DCs: autologous tumor-derived cells subjected to electrofusion will induce a clinical response as assessed by tumor response and will induce an immune response.
18 Years and older (Adult, Senior)
February 28, 2008
March 28, 2017
BIDMC Boston, Massachusetts, United States
† Study has passed its completion date and status has not been verified in more than two years.